169 related articles for article (PubMed ID: 19838217)
1. Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
Yang J; Parsons J; Nicolay NH; Caporali S; Harrington CF; Singh R; Finch D; D'Atri S; Farmer PB; Johnston PG; McKenna WG; Dianov G; Sharma RA
Oncogene; 2010 Jan; 29(3):463-8. PubMed ID: 19838217
[TBL] [Abstract][Full Text] [Related]
2. The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta.
Vaisman A; Chaney SG
J Biol Chem; 2000 Apr; 275(17):13017-25. PubMed ID: 10777605
[TBL] [Abstract][Full Text] [Related]
3. DNA polymerase β-dependent cell survival independent of XRCC1 expression.
Horton JK; Gassman NR; Dunigan BD; Stefanick DF; Wilson SH
DNA Repair (Amst); 2015 Feb; 26():23-9. PubMed ID: 25541391
[TBL] [Abstract][Full Text] [Related]
4. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
5. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.
Albertella MR; Green CM; Lehmann AR; O'Connor MJ
Cancer Res; 2005 Nov; 65(21):9799-806. PubMed ID: 16267001
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity of DNA polymerase beta null mouse fibroblasts reflects accumulation of cytotoxic repair intermediates from site-specific alkyl DNA lesions.
Horton JK; Joyce-Gray DF; Pachkowski BF; Swenberg JA; Wilson SH
DNA Repair (Amst); 2003 Jan; 2(1):27-48. PubMed ID: 12509266
[TBL] [Abstract][Full Text] [Related]
7. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
Bassett E; Vaisman A; Tropea KA; McCall CM; Masutani C; Hanaoka F; Chaney SG
DNA Repair (Amst); 2002 Dec; 1(12):1003-16. PubMed ID: 12531010
[TBL] [Abstract][Full Text] [Related]
8. 'Knock down' of DNA polymerase beta by RNA interference: recapitulation of null phenotype.
Polosina YY; Rosenquist TA; Grollman AP; Miller H
DNA Repair (Amst); 2004 Nov; 3(11):1469-74. PubMed ID: 15380102
[TBL] [Abstract][Full Text] [Related]
9. DNA synthesis and dRPase activities of polymerase beta are both essential for single-nucleotide patch base excision repair in mammalian cell extracts.
Podlutsky AJ; Dianova II; Wilson SH; Bohr VA; Dianov GL
Biochemistry; 2001 Jan; 40(3):809-13. PubMed ID: 11170398
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
[TBL] [Abstract][Full Text] [Related]
11. DNA polymerases beta and lambda mediate overlapping and independent roles in base excision repair in mouse embryonic fibroblasts.
Braithwaite EK; Kedar PS; Stumpo DJ; Bertocci B; Freedman JH; Samson LD; Wilson SH
PLoS One; 2010 Aug; 5(8):e12229. PubMed ID: 20805875
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies on the mechanisms of oxaliplatin resistance.
Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
[TBL] [Abstract][Full Text] [Related]
13. Involvement of DNA polymerase beta in repairing oxidative damages induced by antitumor drug adriamycin.
Liu S; Wu M; Zhang Z
Toxicol Appl Pharmacol; 2010 Aug; 246(3):163-70. PubMed ID: 20510258
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
[TBL] [Abstract][Full Text] [Related]
15. Involvement of DNA polymerase beta in protection against the cytotoxicity of oxidative DNA damage.
Horton JK; Baker A; Berg BJ; Sobol RW; Wilson SH
DNA Repair (Amst); 2002 Apr; 1(4):317-33. PubMed ID: 12509250
[TBL] [Abstract][Full Text] [Related]
16. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death.
Trivedi RN; Almeida KH; Fornsaglio JL; Schamus S; Sobol RW
Cancer Res; 2005 Jul; 65(14):6394-400. PubMed ID: 16024643
[TBL] [Abstract][Full Text] [Related]
17. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
[TBL] [Abstract][Full Text] [Related]
18. Protein interactions with platinum-DNA adducts: from structure to function.
Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
[TBL] [Abstract][Full Text] [Related]
19. DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy.
Nemec AA; Abriola L; Merkel JS; de Stanchina E; DeVeaux M; Zelterman D; Glazer PM; Sweasy JB
Mol Cancer Res; 2017 Mar; 15(3):269-280. PubMed ID: 28074003
[TBL] [Abstract][Full Text] [Related]
20. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
Chaney SG; Campbell SL; Bassett E; Wu Y
Crit Rev Oncol Hematol; 2005 Jan; 53(1):3-11. PubMed ID: 15607931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
